Moderna Plans to Expand the Size of the Clinical Trial Testing for Kids Under 12
Moderna has planned to increase the size of its clinical trial testing for COVID-19 vaccines for children ages 5 to 11 years old, the vaccine company said. The trial, which began in late March, is being expanded to boost the …